Michele Ilene Korfin

Chief Operating Officer, TYME TECHNOLOGIES, INC.

Companies

Organogenesis Holdings Inc.Board member May 5, 2022 to now¹
Gamida Cell Ltd.Chief operating officer Jan 3, 2022 to Feb 2, 2024²
TYME TECHNOLOGIES, INC.Chief operating officer Mar 25, 2019 to May 18, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Organogenesis Holdings Inc. ORGO239,073 shares⁴$235.3K at $0.98Feb 18, 2026
Gamida Cell Ltd.702,981 shares⁵Jan 31, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 18, 2026Granted 48,828 shares of Organogenesis Holdings Inc.⁴
Feb 19, 2025Granted 49,575 shares of Organogenesis Holdings Inc.⁶
Feb 21, 2024Granted 51,020 shares of Organogenesis Holdings Inc.⁷
Jan 31, 2024Granted 480,319 shares of Gamida Cell Ltd.⁵
Feb 22, 2023Granted 65,737 shares of Organogenesis Holdings Inc.⁸
Feb 8, 2023Granted 92,990 shares of Gamida Cell Ltd.⁹
May 3, 2022Granted 23,913 shares of Organogenesis Holdings Inc.¹⁰
Jan 28, 2022Granted 63,800 shares of Gamida Cell Ltd.¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROrganogenesis Holdings Inc., Board member
2
SEC EDGARGamida Cell Ltd., Chief operating officer
3
SEC EDGARTYME TECHNOLOGIES, INC., Chief operating officer
4
SEC EDGAROrganogenesis Holdings Inc. shares after the filing of Feb 18, 2026
5
SEC EDGARGamida Cell Ltd. shares after the filing of Jan 31, 2024
6
SEC EDGARForm 4 filed Feb 21, 2025
7
SEC EDGARForm 4 filed Feb 23, 2024
8
SEC EDGARForm 4 filed Feb 24, 2023
9
SEC EDGARForm 4 filed Feb 10, 2023
10
SEC EDGARForm 4 filed May 5, 2022
11
SEC EDGARForm 4 filed Feb 1, 2022